Citation Impact
Citing Papers
Diabetes and Cardiovascular Disease
1999 Standout
National High Blood Pressure Education Program Working Group report on hypertension in diabetes.
1994
Angiotensin II causes hypertension and cardiac hypertrophy through its receptors in the kidney
2006 StandoutNobel
Prevention of diabetic nephropathy with enalapril in normotensive diabetics with microalbuminuria.
1988
Microalbuminuria as predictor of increased mortality in elderly people.
1990
The course of kidney function in Type 2 (non-insulin-dependent) diabetic patients with diabetic nephropathy
1993
Urinary albumin excretion rate and glomerular filtration rate in the prediction of diabetic nephropathy; a long‐term follow‐up study of childhood onset type‐1 diabetic patients
2001
Effect of lipid reduction on the progression of renal disease: A meta-analysis
2001
Dual blockade of the renin-angiotensin system in type 1 patients with diabetic nephropathy
2002
Prevalence of micro- and macroalbuminuria, arterial hypertension, retinopathy and large vessel disease in European Type 2 (non-insulin-dependent) diabetic patients
1991
Pathophysiology of Progressive Nephropathies
1998 Standout
Microalbuminuria in prediction and prevention of diabetic nephropathy in insulin-dependent diabetes mellitus patients
1995
Should We STOP Angiotensin Converting Enzyme Inhibitors/Angiotensin Receptor Blockers in Advanced Kidney Disease?
2016 Standout
A Comparison of Outcomes with Angiotensin-Converting–Enzyme Inhibitors and Diuretics for Hypertension in the Elderly
2003
Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes
2016 Standout
Treatment of arterial hypertension in diabetic humans: Importance of therapeutic selection
1992
Cross sectional longitudinal study of spot morning urine protein:creatinine ratio, 24 hour urine protein excretion rate, glomerular filtration rate, and end stage renal failure in chronic renal disease in patients without diabetes
1998
Effects of aggressive blood pressure control in normotensive type 2 diabetic patients on albuminuria, retinopathy and strokes
2002
Prevalence and causes of albuminuria in non-insulin-dependent diabetic patients
1992
Short and long term effects of antihypertensive therapy in the diabetic rat
1989
Baseline characteristics of participants in the appropriate blood pressure control in diabetes trial
1996
The Effect of Irbesartan on the Development of Diabetic Nephropathy in Patients with Type 2 Diabetes
2001 Standout
A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction Equation
1999 Standout
Proteinuria reduction and progression to renal failure in patients with type 2 diabetes mellitus and overt nephropathy
2005
Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy: Lessons from RENAAL
2004
Effects of Losartan on Renal and Cardiovascular Outcomes in Patients with Type 2 Diabetes and Nephropathy
2001 Standout
More Informative Abstracts Revisited
1990
Effect of captopril or imidapril on the progression of diabetic nephropathy in Japanese with type 1 diabetes mellitus: a randomized controlled study (JAPAN-IDDM)
2002
The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE>
2003 Standout
Independent and Additive Impact of Blood Pressure Control and Angiotensin II Receptor Blockade on Renal Outcomes in the Irbesartan Diabetic Nephropathy Trial
2005
Renal function and requirement for dialysis in chronic nephropathy patients on long-term ramipril: REIN follow-up trial
1998
Renoprotective Effect of the Angiotensin-Receptor Antagonist Irbesartan in Patients with Nephropathy Due to Type 2 Diabetes
2001 Standout
Kidney morphological changes in relation to long-term renal function and metabolic control in adolescents with IDDM
1998
Evidence for renoprotection by blockade of the renin–angiotensin–aldosterone system in hypertension and diabetes
2006
Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
2003 Standout
The renoprotective properties of angiotensin-converting enzyme inhibitors in a chronic model of membranous nephropathy are solely due to the inhibition of angiotensin II: Evidence based on comparative studies with a receptor antagonist
1997
Familial Clustering of Cardiovascular Disease in Patients with Insulin-Dependent Diabetes and Nephropathy
1992
Activin-like kinase 3 is important for kidney regeneration and reversal of fibrosis
2012
Effects of captopril treatment versus placebo on renal function in type 2 diabetic patients with microalbuminuria: a long-term study
1994
Microalbuminuria and hypertension with focus on type 1 and type 2 diabetes*
2003
Management of High Blood Pressure in African Americans<subtitle>Consensus Statement of the Hypertension in African Americans Working Group of the International Society on Hypertension in Blacks</subtitle>
2003
Magnesium Replacement Improves the Metabolic Profile in Obese and Pre-Diabetic Patients with Mild-to-Moderate Chronic Kidney Disease: A 3-Month, Randomised, Double-Blind, Placebo-Controlled Study
2017 Standout
Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study
1995 Standout
Proximal tubular basement membrane width in insulin-dependent diabetes mellitus
1998
Role of the deletion of polymorphism of the angiotensin converting enzyme gene in the progression and therapeutic responsiveness of IgA nephropathy.
1995
Impact of low-dose acetylsalicylic acid on kidney function in type 2 diabetic patients with elevated urinary albumin excretion rate
2003
Mechanisms underlying transition from acute glomerular injury to late glomerular sclerosis in a rat model of nephrotic syndrome.
1988
Appropriate Blood Pressure Control in NIDDM (ABCD) Trial
1996
The Effect of Nisoldipine as Compared with Enalapril on Cardiovascular Outcomes in Patients with Non-Insulin-Dependent Diabetes and Hypertension
1998
Glomerular size-selective dysfunction in NIDDM is not ameliorated by ACE inhibition or by calcium channel blockade
1999
Preventing Microalbuminuria in Type 2 Diabetes
2004
Renal Insufficiency in the Absence of Albuminuria and Retinopathy Among Adults With Type 2 Diabetes Mellitus
2003
A New Equation to Estimate Glomerular Filtration Rate
2009 Standout
ACE inhibitor mediated reductions in renal size and microalbuminuria in normotensive, diabetic subjects
1994
2007 Guidelines for the Management of Arterial Hypertension
2007 Standout
Risk factors for development of incipient and overt diabetic nephropathy in patients with non-insulin dependent diabetes mellitus: prospective, observational study
1997
Estimating Glomerular Filtration Rate from Serum Creatinine and Cystatin C
2012 Standout
Protein intake and urinary albumin excretion rates in the EURODIAB IDDM Complications Study
1997
Multi-Ethnic Study of Atherosclerosis: Objectives and Design
2002 Standout
Diabetic Retinopathy
2012 Standout
Chronic proteinuric nephropathies: Outcomes and response to treatment in a prospective cohort of 352 patients with different patterns of renal injury
2000
Effect of 5-year enalapril therapy on progression of microalbuminuria and glomerular structural changes in type 1 diabetic subjects
2003
Antihypertensive therapy in type 2 diabetes: implications of the appropriate blood pressure control in diabetes (ABCD) trial
1998
Microalbuminuria and ACE inhibition in non-hypertensive diabetics
1990
Effect of deletion polymorphism of angiotensin converting enzyme gene on progression of diabetic nephropathy during inhibition of angiotensin converting enzyme: observational follow up study
1996
Distinct roles for the kidney and systemic tissues in blood pressure regulation by the renin-angiotensin system
2005 StandoutNobel
Predictors of the progression of renal insufficiency in patients with insulin-dependent diabetes and overt diabetic nephropathy
1996
Hyperglycemia: An Independent Marker of In-Hospital Mortality in Patients with Undiagnosed Diabetes
2002 Standout
Renoprotective properties of ACE-inhibition in non-diabetic nephropathies with non-nephrotic proteinuria
1999
Effects of perindopril on renal histomorphometry in diabetic subjects with microalbuminuria: A 3-year placebo-controlled biopsy study
1998
Global and societal implications of the diabetes epidemic
2001 StandoutNature
10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes
2008 Standout
Long-term comparison between perindopril and nifedipine in normotensive patients with type 1 diabetes and microalbuminuria
2001
Type 2 Diabetic Patients with Nephropathy Show Structural—Functional Relationships that Are Similar to Type 1 Disease
2000
Effect of low-dose ramipril on microalbuminuria in normotensive or mild hypertensive non-insulin-dependent diabetic patients*
1995
Long-Term Complications of Diabetes Mellitus
1993 Standout
Effect of Intensive Blood Pressure Control With Valsartan on Urinary Albumin Excretion in Normotensive Patients With Type 2 Diabetes
2006
Randomised controlled trial of dual blockade of renin-angiotensin system in patients with hypertension, microalbuminuria, and non-insulin dependent diabetes: the candesartan and lisinopril microalbuminuria (CALM) study
2000
Long‐term renoprotection by perindopril or nifedipine in non‐hypertensive patients with Type 2 diabetes and microalbuminuria
2004
EMT: 2016
2016 Standout
The Effect of Long-Term Intensified Insulin Treatment on the Development of Microvascular Complications of Diabetes Mellitus
1993
Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38
1998 Standout
Additive antiproteinuric effect of combined ACE inhibition and angiotensin II receptor blockade
2002
Alzheimer's Disease
2010 Standout
Calcium channel blockers versus other antihypertensive therapies on progression of NIDDM associated nephropathy
1996
Additional Antiproteinuric Effect of Ultrahigh Dose Candesartan
2005
The hormone resistin links obesity to diabetes
2001 StandoutNature
Prevention of diabetic renal disease with special reference to microalbuminuria
1995
Biochemistry and molecular cell biology of diabetic complications
2001 StandoutNature
Glucose Control and Vascular Complications in Veterans with Type 2 Diabetes
2008 Standout
Effects of dietary protein restriction on the progression of advanced renal disease in the modification of diet in renal disease study
1996
Dual blockade of the renin-angiotensin system versus maximal recommended dose of ACE inhibition in diabetic nephropathy
2003
Understanding the nature of renal disease progression
1997
The Hallmarks of Aging
2013 Standout
Beneficial impact of spironolactone on nephrotic range albuminuria in diabetic nephropathy
2006
Long-term comparison of losartan and enalapril on kidney function in hypertensive type 2 diabetics with early nephropathy
2000
The Effect of Angiotensin-Converting-Enzyme Inhibition on Diabetic Nephropathy
1993 Standout
Microalbuminuria is not rare before 5 years of IDDM
1994
The beneficial effect of angiotensin-converting enzyme inhibition with captopril on diabetic nephropathy in normotensive IDDM patients with microalbuminuria
1995
Reduced angiotensinogen expression attenuates renal interstitial fibrosis in obstructive nephropathy in mice
1999 StandoutNobel
Renal function and structure in albuminuric type 2 diabetic patients without retinopathy
2001
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
2015 Standout
Possible effect of angiotensin-converting enzyme inhibition on glomerular charge selectivity
1995
Antihypertensive treatment in patients with type-2 diabetes mellitus
2002
Enhanced atherosclerosis and kidney dysfunction in eNOS–/–Apoe–/– mice are ameliorated by enalapril treatment
2000 StandoutNobel
Chronic Kidney Disease and the Risks of Death, Cardiovascular Events, and Hospitalization
2004 Standout
Enhanced renoprotective effects of ultrahigh doses of irbesartan in patients with type 2 diabetes and microalbuminuria
2005
Evolution, consequences and future of plant and animal domestication
2002 StandoutNature
Familial factors determine the development of diabetic nephropathy in patients with IDDM
1996
Lisinopril reduces albuminuria during exercise in low grade microalbuminuric Type 1 diabetic patients: a double blind randomized study
2001
Effect of dietary protein restriction on prognosis in patients with diabetic nephropathy
2002
Circadian variation of blood pressure in patients with diabetic nephropathy
1992
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
The Irbesartan Type II Diabetic Nephropathy Trial: study design and baseline patient characteristics
2000
Time course of the antiproteinuric and antihypertensive effect of losartan in diabetic nephropathy
2003
Lack of impact of low-dose acetylsalicylic acid on kidney function in type 1 diabetic patients with microalbuminuria.
2000
The Rising Global Burden of Diabetes and its Complications: Estimates and Projections to the Year 2010
1997
Medical management of nephropathy in type I diabetes mellitus
1995
Diabetic Nephropathy: Diagnosis, Prevention, and Treatment
2005 Standout
Self-Assembled Monolayers of Thiolates on Metals as a Form of Nanotechnology
2005 Standout
Long-Term Dual Blockade With Candesartan and Lisinopril in Hypertensive Patients With Diabetes
2005
Angiotensin-Converting Enzyme Inhibition and Renal Protection
1993
Effect of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers on All-Cause Mortality, Cardiovascular Deaths, and Cardiovascular Events in Patients With Diabetes Mellitus
2014
Diabetic nephropathy is markedly enhanced in mice lacking the bradykinin B2 receptor
2004 StandoutNobel
Genetically increased angiotensin I-converting enzyme level and renal complications in the diabetic mouse
2001 StandoutNobel
Epithelial-to-mesenchymal transition induces cell cycle arrest and parenchymal damage in renal fibrosis
2015 StandoutNobel
The association of microalbuminuria and mortality in non-insulin-dependent diabetes mellitus. A systematic overview of the literature.
1997
Comparative Study of the Effect of ACE-Inhibitors and Other Antihypertensive Agents on Proteinuria in Diabetic Patients
1994
Reduction of ACE Activity Is Insufficient to Decrease Microalbuminuria in Normotensive Patients With Type 1 Diabetes
2001
The Early Natural History of Nephropathy in Type 1 Diabetes
2002
The Effect of Dietary Protein Restriction on the Progression of Diabetic and Nondiabetic Renal Diseases
1996
Microalbuminuria is positively associated with usual dietary saturated fat intake and negatively associated with usual dietary protein intake in people with insulin-dependent diabetes mellitus
1998
Protein Kinase C β Inhibition Attenuates the Progression of Experimental Diabetic Nephropathy in the Presence of Continued Hypertension
2003
Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 Diabetes
2005 Standout
ACE-I and ARBs in early diabetic nephropathy
2002
Effect of captopril on progression to clinical proteinuria in patients with insulin-dependent diabetes mellitus and microalbuminuria. European Microalbuminuria Captopril Study Group.
1994
Angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists for preventing the progression of diabetic kidney disease
2006
Long-term renoprotective effect of angiotensin-converting enzyme inhibition in non-insulin-dependent diabetes mellitus. A 7-year follow-up study.
1996
[Effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes].
2001 Standout
Converting enzyme inhibition and kidney function in normotensive diabetic patients with persistent microalbuminuria.
1987
Angiotensin-Converting Enzyme Inhibitors and Progression of Nondiabetic Renal Disease
2001
Long-term Effects of Antihypertensive Agents on Proteinuria and Renal Function
1995
The losartan renal protection study — rationale, study design and baseline characteristics of RENAAL (Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan)
2000
Chain-length-dependent change in the structure of self-assembled monolayers of n-alkanethiols on Au(111) probed by broad-bandwidth sum frequency generation spectroscopy
2003
Arterial Hypertension, Microalbuminuria, and Risk of Ischemic Heart Disease
2000
Prevalence of Arterial Hypertension in Diabetic Patients Before and After the JNC-V
1994
Glomerular structure and function in proteinuric Type 2 (non-insulin-dependent) diabetic patients
1993
Effects of an Angiotensin-Converting–Enzyme Inhibitor, Ramipril, on Cardiovascular Events in High-Risk Patients
2000 Standout
High glucose level unmasks a genetic predisposition to enhanced extracellular matrix production in mesangial cells from the Milan normotensive strain.
1997
More Informative Abstracts Revisited
1991
Multifactorial Intervention and Cardiovascular Disease in Patients with Type 2 Diabetes
2003 Standout
Use of Enalapril To Attenuate Decline in Renal Function in Normotensive, Normoalbuminuric Patients with Type 2 Diabetes Mellitus
1998
The need for early predictors of diabetic nephropathy risk: is albumin excretion rate sufficient?
2000
Adenoviral transfer of HIF-1α enhances vascular responses to critical limb ischemia in diabetic mice
2009 StandoutNobel
Renal protective effect of enalapril in diabetic nephropathy.
1992
Microalbuminuria as a Risk Predictor in Diabetes: The Continuing Saga
2014
Identification and Management of Diabetic Nephropathy in the Diabetes Clinic
2003
Glomerular structural changes in Type 1 (insulin-dependent) diabetes mellitus: causes, consequences, and prevention
1992
Kidney volume in type 1 (insulin-dependent) diabetic patients with normal or increased urinary albumin excretion: effect of long-term improved metabolic control
1991
Pharmacogenomics: Translating Functional Genomics into Rational Therapeutics
1999 StandoutScience
Cellular Basis of Diabetic Nephropathy
2002
Dapagliflozin in Patients with Chronic Kidney Disease
2020 Standout
Urinary Albumin Excretion as a Predictor of Diabetic Retinopathy, Neuropathy, and Cardiovascular Disease in NIDDM
1996
The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes Mellitus
1993 Standout
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
2018 Standout
Predictors of the development of microalbuminuria in patients with Type 1 diabetes mellitus: a seven‐year prospective study
1999
Kidney Function During and After Withdrawal of Long-Term Irbesartan Treatment in Patients With Type 2 Diabetes and Microalbuminuria
2003
Long-term renoprotective effect of nisoldipine and lisinopril in type 1 diabetic patients with diabetic nephropathy.
2000
Reduced growth, abnormal kidney structure, and type 2 (AT 2 ) angiotensin receptor-mediated blood pressure regulation in mice lacking both AT 1A and AT 1B receptors for angiotensin II
1998 StandoutNobel
Interactions of Transforming Growth Factor-β and Angiotensin II in Renal Fibrosis
1998
Familial clustering of diabetic nephropathy in Brazilian type 2 diabetic patients.
1999
Smoking and Progression of Diabetic Nephropathy in Type 1 Diabetes
2003
Works of E. Hommel being referenced
Prognosis in diabetic nephropathy.
1989
Protection of kidney function and decrease in albuminuria by captopril in insulin dependent diabetics with nephropathy.
1988
Effect of captopril on blood pressure and kidney function in normotensive insulin dependent diabetics with nephropathy.
1989
Increased blood pressure and erythrocyte sodium/lithium countertransport activity are not inherited in diabetic nephropathy
1990
Prevalence of microalbuminuria, arterial hypertension, retinopathy, and neuropathy in patients with insulin dependent diabetes
1988
On the pathogenesis of arterial blood pressure elevation early in the course of diabetic nephropathy
1989
Is diabetic nephropathy an inherited complication?
1992
Plasma lipoproteins and renal function during simvastatin treatment in diabetic nephropathy
1992
Long-term beneficial effect of ACE inhibition on diabetic nephropathy in normotensive type 1 diabetic patients
2001
Retinal function in relation to improved glycaemic control in type 1 diabetes
2011
Prevalence and causes of microscopic haematuria in Type 1 (insulin-dependent) diabetic patients with persistent proteinuria
1987
Benefits of long-term antihypertensive treatment on prognosis in diabetic nephropathy
1996
Angiotensin-converting enzyme inhibition in diabetic nephropathy: Ten years' experience
1995
Randomised controlled trial of long term efficacy of captopril on preservation of kidney function in normotensive patients with insulin dependent diabetes and microalbuminuria
1999
Elevated Urinary Prostaglandin Excretion and the Effect of Indomethacin on Renal Function in Incipient Diabetic Nephropathy
1988
Broadband Vibrational Sum Frequency Generation Spectroscopy of a Liquid Surface
2001
Reduction in albuminuria predicts a beneficial effect on diminishing the progression of human diabetic nephropathy during antihypertensive treatment
1994
Effective Antihypertensive Treatment Postpones Renal Insufficiency in Diabetic Nephropathy
1993
Impaired autoregulation of the glomerular filtration rate in patients with nondiabetic nephropathies
1999
Effect of captopril on kidney function in insulin-dependent diabetic patients with nephropathy.
1986
Prevalence of microalbuminuria in children with Type 1 (insulin-dependent) diabetes mellitus
1986
Reduction in albuminuria predicts diminished progression in diabetic nephropathy.
1994
Efficacy of captopril in postponing nephropathy in normotensive insulin dependent diabetic patients with microalbuminuria.
1991
Effects of indomethacin on kidney function in Type 1 (insulin-dependent) diabetic patients with nephropathy
1987
Effect of antihypertensive treatment on kidney function in diabetic nephropathy.
1987
Acute reduction of arterial blood pressure reduces urinary albumin excretion in Type 1 (insulin-dependent) diabetic patients with incipient nephropathy
1986
Glomerular Structure and Function in Diabetic Nephropathy: Early to Advanced Stages
1990
Prevalence of Hyperglycaemia and Undiagnosed Diabetes Mellitus in Patients with Acute Myocardial Infarction
1986
Effects of acetazolamide on kidney function in Type 1 (insulin-dependent) diabetic patients with diabetic nephropathy
1988
Lack of familial predisposition to cardiovascular disease in Type 1 (insulin-dependent) diabetic patients with nephropathy
1991
A strong correlation between glomerular filtration rate and filtration surface in diabetic nephropathy
1988
Impact of arterial blood pressure and albuminuria on the progression of diabetic nephropathy in IDDM patients
1993
Effects of long-term antihypertensive treatment on kidney function in diabetic nephropathy.
1985
Microalbuminuria: An Early Marker of Renal Involvement in Diabetes
1985
Impact of Arterial Blood Pressure and Albuminuria on the Progression of Diabetic Nephropathy in IDDM Patients
1993
Antihypertensive treatment postpones end-stage renal failure in diabetic nephropathy.
1988